These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 28374966)

  • 1. Apoptosis, Dysbiosis and Expression of Inflammatory Cytokines are Sequential Events in the Development of 5-Fluorouracil-Induced Intestinal Mucositis in Mice.
    Hamouda N; Sano T; Oikawa Y; Ozaki T; Shimakawa M; Matsumoto K; Amagase K; Higuchi K; Kato S
    Basic Clin Pharmacol Toxicol; 2017 Sep; 121(3):159-168. PubMed ID: 28374966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-HT₃ receptor antagonists ameliorate 5-fluorouracil-induced intestinal mucositis by suppression of apoptosis in murine intestinal crypt cells.
    Yasuda M; Kato S; Yamanaka N; Iimori M; Matsumoto K; Utsumi D; Kitahara Y; Amagase K; Horie S; Takeuchi K
    Br J Pharmacol; 2013 Mar; 168(6):1388-400. PubMed ID: 23072534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probiotic Bifidobacterium bifidum G9-1 attenuates 5-fluorouracil-induced intestinal mucositis in mice via suppression of dysbiosis-related secondary inflammatory responses.
    Kato S; Hamouda N; Kano Y; Oikawa Y; Tanaka Y; Matsumoto K; Amagase K; Shimakawa M
    Clin Exp Pharmacol Physiol; 2017 Oct; 44(10):1017-1025. PubMed ID: 28590519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential role of the NADPH oxidase NOX1 in the pathogenesis of 5-fluorouracil-induced intestinal mucositis in mice.
    Yasuda M; Kato S; Yamanaka N; Iimori M; Utsumi D; Kitahara Y; Iwata K; Matsuno K; Amagase K; Yabe-Nishimura C; Takeuchi K
    Am J Physiol Gastrointest Liver Physiol; 2012 May; 302(10):G1133-42. PubMed ID: 22403796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteration of Gut Microbiota and Inflammatory Cytokine/Chemokine Profiles in 5-Fluorouracil Induced Intestinal Mucositis.
    Li HL; Lu L; Wang XS; Qin LY; Wang P; Qiu SP; Wu H; Huang F; Zhang BB; Shi HL; Wu XJ
    Front Cell Infect Microbiol; 2017; 7():455. PubMed ID: 29124041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-1 receptor antagonist reduced apoptosis and attenuated intestinal mucositis in a 5-fluorouracil chemotherapy model in mice.
    Wu ZQ; Han XD; Wang Y; Yuan KL; Jin ZM; Di JZ; Yan J; Pan Y; Zhang P; Huang XY; Wang ZG; Zheng Q
    Cancer Chemother Pharmacol; 2011 Jul; 68(1):87-96. PubMed ID: 20844880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Administration of probiotic mixture DM#1 ameliorated 5-fluorouracil-induced intestinal mucositis and dysbiosis in rats.
    Tang Y; Wu Y; Huang Z; Dong W; Deng Y; Wang F; Li M; Yuan J
    Nutrition; 2017 Jan; 33():96-104. PubMed ID: 27427511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Saireito (TJ-114), a Japanese traditional herbal medicine, reduces 5-fluorouracil-induced intestinal mucositis in mice by inhibiting cytokine-mediated apoptosis in intestinal crypt cells.
    Kato S; Hayashi S; Kitahara Y; Nagasawa K; Aono H; Shibata J; Utsumi D; Amagase K; Kadowaki M
    PLoS One; 2015; 10(1):e0116213. PubMed ID: 25565296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral Administration of Polaprezinc Attenuates Fluorouracil-induced Intestinal Mucositis in a Mouse Model.
    Liu Z; Xie W; Li M; Teng N; Liang X; Zhang Z; Yang Z; Wang X
    Basic Clin Pharmacol Toxicol; 2017 Dec; 121(6):480-486. PubMed ID: 28667794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of platelet-activating factor in the pathogenesis of 5-fluorouracil-induced intestinal mucositis in mice.
    Soares PM; Lima-Junior RC; Mota JM; Justino PF; Brito GA; Ribeiro RA; Cunha FQ; Souza MH
    Cancer Chemother Pharmacol; 2011 Sep; 68(3):713-20. PubMed ID: 21153821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effect of Bu-Zhong-Yi-Qi decoction, the water extract of Chinese traditional herbal medicine, on 5-fluorouracil-induced intestinal mucositis in mice.
    Gou H; Gu LY; Shang BZ; Xiong Y; Wang C
    Hum Exp Toxicol; 2016 Dec; 35(12):1243-1251. PubMed ID: 26801985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diadzein ameliorates 5-fluorouracil-induced intestinal mucositis by suppressing oxidative stress and inflammatory mediators in rodents.
    Atiq A; Shal B; Naveed M; Khan A; Ali J; Zeeshan S; Al-Sharari SD; Kim YS; Khan S
    Eur J Pharmacol; 2019 Jan; 843():292-306. PubMed ID: 30529194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Irinotecan- and 5-fluorouracil-induced intestinal mucositis: insights into pathogenesis and therapeutic perspectives.
    Ribeiro RA; Wanderley CW; Wong DV; Mota JM; Leite CA; Souza MH; Cunha FQ; Lima-Júnior RC
    Cancer Chemother Pharmacol; 2016 Nov; 78(5):881-893. PubMed ID: 27590709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alanyl-glutamine attenuates 5-fluorouracil-induced intestinal mucositis in apolipoprotein E-deficient mice.
    Araújo CV; Lazzarotto CR; Aquino CC; Figueiredo IL; Costa TB; Alves LA; Ribeiro RA; Bertolini LR; Lima AA; Brito GA; Oriá RB
    Braz J Med Biol Res; 2015 Jun; 48(6):493-501. PubMed ID: 25945744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein E COG 133 mimetic peptide improves 5-fluorouracil-induced intestinal mucositis.
    Azevedo OG; Oliveira RA; Oliveira BC; Zaja-Milatovic S; Araújo CV; Wong DV; Costa TB; Lucena HB; Lima RC; Ribeiro RA; Warren CA; Lima AÂ; Vitek MP; Guerrant RL; Oriá RB
    BMC Gastroenterol; 2012 Jul; 12():35. PubMed ID: 22524518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective role of casuarinin from Melastoma malabathricum against a mouse model of 5-fluorouracil-induced intestinal mucositis: Impact on inflammation and gut microbiota dysbiosis.
    Chen KJ; Huang YL; Kuo LM; Chen YT; Hung CF; Hsieh PW
    Phytomedicine; 2022 Jul; 101():154092. PubMed ID: 35430483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new animal model of intestinal mucositis induced by the combination of irinotecan and 5-fluorouracil in mice.
    Pereira VB; Melo AT; Assis-Júnior EM; Wong DV; Brito GA; Almeida PR; Ribeiro RA; Lima-Júnior RC
    Cancer Chemother Pharmacol; 2016 Feb; 77(2):323-32. PubMed ID: 26666645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dipeptidyl-peptidase-4 (DPP-4) inhibitor ameliorates 5-flurouracil induced intestinal mucositis.
    Lee JM; Yoo IK; Lee JM; Kim SH; Choi HS; Kim ES; Keum B; Seo YS; Jeen YT; Chun HJ; Lee HS; Um SH; Kim CD
    BMC Cancer; 2019 Oct; 19(1):1016. PubMed ID: 31664952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutrophil elastase inhibitor (MPH-966) improves intestinal mucosal damage and gut microbiota in a mouse model of 5-fluorouracil-induced intestinal mucositis.
    Chen KJ; Chen YL; Ueng SH; Hwang TL; Kuo LM; Hsieh PW
    Biomed Pharmacother; 2021 Feb; 134():111152. PubMed ID: 33373916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lafutidine, a histamine H2 receptor antagonist with mucosal protective properties, attenuates 5-fluorouracil-induced intestinal mucositis in mice through activation of extrinsic primary afferent neurons.
    Sano T; Utsumi D; Amagase K; Matsumoto K; Tominaga M; Higuchi K; Takeuchi T; Kato S
    J Physiol Pharmacol; 2017 Feb; 68(1):79-90. PubMed ID: 28456772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.